While stigma experienced by people living with HIV (PLWH) is well documented, intersectional stigma and additional stigmatized identities have not received similar attention. The purpose of this metasynthesis is to identify salient stigmatized intersections and their impact on health outcomes in PLWH in sub-Saharan Africa. Using Sandelowski and Barroso’s metasynthesis method, we searched four databases for peer-reviewed qualitative literature. Included studies (1) explored personal experiences with intersecting stigmas, (2) included ≥1 element of infectious disease stigma, and (3) were conducted in sub-Saharan Africa. Our multinational team extracted, aggregated, interpreted, and synthesized the findings. From 454 screened abstracts, the 34 studies included in this metasynthesis reported perspectives of at least 1258 participants (282 men, 557 women, and 109 unspecified gender) and key informants. From these studies, gender and HIV was the most salient stigmatized intersection, with HIV testing avoidance and HIV-status denial seemingly more common among men to preserve traditional masculine identity. HIV did not threaten female identity in the same way with women more willing to test for HIV, but at the risk of abandonment and withdrawal of financial support. To guard against status loss, men and women used performative behaviors to highlight positive qualities or minimize perceived negative attributes. These identity management practices ultimately shaped health behaviors and outcomes. From this metasynthesis, the Stigma Identity Framework was devised for framing identity and stigma management, focusing on role expectation and fulfillment. This framework illustrates how PLWH create, minimize, or emphasize other identity traits to safeguard against status loss and discrimination. Providers must acknowledge how stigmatization disrupts PLWH’s ability to fit into social schemas and tailor care to individuals’ unique intersecting identities. Economic security and safety should be considered in women’s HIV care, while highlighting antiretrovirals’ role in preserving strength and virility may improve care engagement among men.
Key Points: Qualitative research that explores hemodialysis patient perspectives about adherence may point to gaps in existing adherence interventions. Patients' goals included balancing treatment and competing priorities, preserving a sense of their “old selves,” and minimizing symptoms. Adherence may improve when clinicians routinely elicit patients' goals and partner to resolve conflicts between those goals and adherence. Background: Patients with ESKD treated with hemodialysis in the United States have persistently higher rates of nonadherence compared with patients in other developed countries. Nonadherence is associated with an increased risk of death and higher medical expenditure. There is an urgent need to address it with feasible, effective interventions as the prevalence of patients on hemodialysis in the United States continues to grow. However, published adherence interventions demonstrate limited long-term efficacy. Methods: We conducted a synthesis of qualitative studies on adherence to hemodialysis treatment, medications, and fluid and dietary restrictions to identify gaps in published adherence interventions, searching PubMed, CINAHL, PsychInfo, Embase, and Web of Science databases. We analyzed qualitative data with a priori codes derived from the World Health Organization's adherence framework and subsequent codes from thematic analysis. Results: We screened 1775 articles and extracted qualitative data from 12. The qualitative data revealed 20 factors unique to hemodialysis across the World Health Organization's five dimensions of adherence. In addition, two overarching themes emerged from the data: (1) adherence in the context of patients' whole lives and (2) dialysis treatment as a double-edged sword. Patient-level factors reflected in the qualitative data extended beyond knowledge about hemodialysis treatment or motivation to adhere to treatment. Patients described a profound grieving process over the loss of their “old self” that impacted adherence. They also navigated complex challenges that could be exacerbated by social determinants of health as they balanced treatment, life tasks, and social roles. Conclusions: This review adds to the growing evidence that one-size-fits-all approaches to improving adherence among patients on hemodialysis are inadequate. Adherence may improve when routine care incorporates patient context and provides ongoing support to patients and families as they navigate the logistical, physical, and psychological hardships of living with dialysis. New research is urgently needed to guide a change in course.
Tuberculosis (TB) stigma is one barrier to TB testing, treatment uptake, and treatment completion. Therefore, stigma measurement must be approached through rigorous scientific methodology in order to accurately and reliably estimate the impact of TB stigma on treatment outcomes. The aim of this systematic review is to evaluate the methods and instruments used to measure TB stigma and interrogate strategies used to culturally validate measures of TB stigma in global research. Two reviewers used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method to extract and analyze the existing body of literature on TB stigma in Sub-Saharan Africa. A thorough search was performed using three databases generating 2,302 independent studies. After the systematic screening, this review includes 28 studies. Of those studies, 13 used a psychometrically validated instrument while 15 used informal questionnaires or proxy variables to measure stigma. The psychometric appraisal was limited due to the number of studies that measured stigma using unvalidated questionnaires or proxy variables. The Patient and Community Perceptions of TB scales validated by Van Rie et al. were the most commonly used instruments to measure TB stigma; additionally, many instruments were not culturally or linguistically validated in Sub-Saharan Africa. Our appraisal emphasizes the need for reliable and valid instruments to measure TB stigma in low- and middle-income countries most affected by TB.
4 October 2022 in Journal of the Association of Nurses in AIDS Care
Monkeypox is a zoonotic infection that manifests as dermatologic lesions that may be painful or pruritic and can appear on the face, trunk, extremities, genitals, and mucosal surfaces. In 2022, cases of monkeypox increased exponentially and it was declared a public health emergency by the World Health Organization and the U.S. Department of Health and Human Services. Unlike previous monkeypox outbreaks, the current situation has disproportionately affected men who have sex with men and seems to be associated with lower mortality. Options for treatment and prevention are limited. The distribution and availability of vaccines and antivirals has posed challenges for patients, clinicians, and public health systems. Early recognition and management of persons with monkeypox is critical in controlling the spread of this infection. This article reviews key features of monkeypox and highlights current recommendations for clinical management, prevention, and considerations for persons with HIV. Implications for public health and nursing are discussed.
Introduction Around the globe, unintended pregnancy rates remain high, especially among women in low and middle-income countries. A major contributor is contraceptive discontinuation. This study aims to synthesize the rates of early hormonal contraceptive discontinuation (i.e., discontinuation prior to 12 months of use) and the impact of side effects on discontinuation. Methods A systematic review of seven databases covered articles published between 2011 and 2021. Observational studies that assessed choices about hormonal contraceptive use were included in the final review. As reported in each article reviewed, the pooled proportions of early contraceptive discontinuation rates were calculated using a random effects model. Qualitative and quantitative data about the influence of side effects on discontinuation of hormonal contraception were synthesized using a narrative approach. Results Fifty studies met the inclusion criteria. The pooled overall early discontinuation rate was 26% (95% CI: 21–32%). The pooled early discontinuation rates for short-acting hormonal methods like oral contraceptives and injectables were 42% (95% CI: 20–67%) and 21% (95% CI: 7–40%), respectively. Meanwhile, the pooled discontinuation rates for long-acting hormonal methods like implants and intrauterine devices were 22% (95% CI: 16–28%) and 17% (95% CI: 11–24%), respectively. The side effects mentioned most frequently as contributing to hormonal contraceptive discontinuation were abnormal bleeding, abdominal pain, nausea, vomiting, cramping, headaches, mood changes, and sexual and genitourinary side effects. Discussion/ Conclusion High rates of early contraceptive discontinuation persist with varying levels of discontinuation based on contraceptive type. Side effects play a major role in hormonal contraceptive discontinuation. However, there is a dearth of evidence on managing side effects, making this an important area for future research.